Cargando…
The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword
Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for CKD include therapeutics to target factors that contribute to CKD progression, including renin–angiotensin–aldosterone system inhibitors, and drugs to control blood pressure and proteinuria control. Recently,...
Autores principales: | Wehedy, Eman, Shatat, Ibrahim F., Al Khodor, Souhaila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801809/ https://www.ncbi.nlm.nih.gov/pubmed/35111779 http://dx.doi.org/10.3389/fmed.2021.790783 |
Ejemplares similares
-
Gut microbiome and kidney disease: a bidirectional relationship
por: Al Khodor, Souhaila, et al.
Publicado: (2016) -
Characterization of the Urinary Metagenome and Virome in Healthy Children
por: Wehedy, Eman, et al.
Publicado: (2022) -
The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure?
por: Al Khodor, Souhaila, et al.
Publicado: (2017) -
The microbiota and chronic kidney diseases: a double-edged sword
por: Felizardo, Raphael Jose Ferreira, et al.
Publicado: (2016) -
Hyaluronan, a double-edged sword in kidney diseases
por: Kaul, Aditya, et al.
Publicado: (2021)